Get ahead of standard treatments for myelofibrosis. Participating in a myelofibrosis clinical trial gives you access to the latest therapies.Call +1 844 627 7246
Myelofibrosis (MF) is a rare form of blood cancer and one of several myeloproliferative neoplasms (MPNs) which originate in bone marrow and cause blood cells to develop and behave abnormally. MF may develop on its own or due to the progression of other myeloproliferative disorders such as polycythemia vera (PV) and essential thrombocythemia (ET). Agnogenic myeloid metaplasia, chronic idiopathic MF, and myelosclerosis with myeloid metaplasia are other names used for MF.
More than 50 percent of MF cases are linked to a mutation in the Janus kinase 2 (JAK2) gene. Other gene mutations are also associated with this myeloproliferative disorder. MF often progresses slowly, and some people go for years without experiencing any symptoms.
Myeloproliferative neoplasms produce an excess of blood cells in bone marrow. White blood cells are more often affected than others, though some myeloproliferative disorders result in excess red blood cells or platelets. There are six types of chronic MPNs:
Doctors recommend myelofibrosis treatment based largely on a patient’s symptoms and other factors, as in other blood cancer treatments such as the presence of anemia, an enlarged spleen, and certain other features of this disease. Because each patient is affected by MF in different ways, MF treatment is tailored to the patient, as in the case of polycythemia vera treatment and other blood cancer treatments. Your doctor will also consider age, blood cell count, amounts of immature blood cells called blasts, and symptoms such as fatigue and severe weight loss.
We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.Access the free matching tool
Massive Bio specializes in finding clinical trials of new treatments for MF and related conditions. If you’ve been diagnosed with MF or any other myeloproliferative neoplasm, we’re here to help. That’s true even if you require advanced myelofibrosis treatment or advanced blood cancer treatment for any other type of myeloproliferative disorder. If your MF has progressed, let us help you find the best treatment options. Using our artificial intelligence-based platform, we can match you to clinical trials of advanced myelofibrosis treatment options today. If you aren’t sure if you have MF or a related condition, that’s okay. Additional testing can help determine your exact diagnosis.
“The patient advocate was knowledgable to understand my rare myelofibrosis case. The nurses were friendly and supported us through clinical trial enrollment process in a couple weeks. I am glad to see of your post on the social media groups.“
Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.
I reached out to Massive Bio after learning of a recent breast cancer diagnosis of a family member. From free expert clinical trial matching to patient advocate support, Massive Bio was able to provide me with the necessary resources and knowledge to provide my family member the support they needed during their cancer journey.
I have recommended this to colleagues for patients that could benefit from clinical trials or have exhausted their treatment options and need a second opinion. Massive Bio’s team puts great minds together to find better solutions for patients that might think they have none left.
We reached out to Massive Bio for a second opinion regarding my Mothers breast cancer diagnosis. Massive Bio provided us with alternative treatment options which were clinically proven to be more effective and with less side effects than the standard level of care our oncologist suggested. Their team was quick to respond, extremely knowledgeable, answered all of our questions. They continue to follow her case, gladly reviewing any new scans and results. We are so grateful for the time and effort they continue to put into her case. Thank you Massive Bio for giving us hope again!
Massive Bio’s team is amazing. They work tirelessly to help patients and providers. This company truly cares about the work they are doing and the care they are delivering.
Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.Call +1 844 627 7246
Clinical trials test the latest scientific advancements in Myelofibrosis treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Myelofibrosis patients might gain access to promising drugs and innovative treatments long before they're made available to the public.
At Massive Bio, our goal is to ensure that all cancer patients have access to clinical trials of innovative new treatments that offer hope for improved outcomes. Our unique SYNERGY-AI technology rapidly generates a personalized clinical trial matching report, which is FREE to patients and doctors.